PMID- 38310873 OWN - NLM STAT- Publisher LR - 20240204 IS - 2233-6087 (Electronic) IS - 2233-6079 (Linking) DP - 2024 Feb 2 TI - Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective. LID - 10.4093/dmj.2023.0350 [doi] AB - It has been generally accepted that insulin resistance (IR) and reduced insulin secretory capacity are the basic pathogenesis of type 2 diabetes mellitus (T2DM). In addition to genetic factors, the persistence of systemic inflammation caused by obesity and the associated threat of lipotoxicity increase the risk of T2DM. In particular, the main cause of IR is obesity and subjects with T2DM have a higher body mass index (BMI) than normal subjects according to recent studies. The prevalence of T2DM with IR has increased with increasing BMI during the past three decades. According to recent studies, homeostatic model assessment of IR was increased compared to that of the 1990s. Rising prevalence of obesity in Korea have contributed to the development of IR, non-alcoholic fatty liver disease and T2DM and cutting this vicious cycle is important. My colleagues and I have investigated this pathogenic mechanism on this theme through clinical and experimental studies over 20 years and herein, I would like to summarize some of our studies with deep gratitude for receiving the prestigious 2023 Sulwon Award. FAU - Jung, Inha AU - Jung I AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea. FAU - Koo, Dae-Jeong AU - Koo DJ AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Changwon Fatima Hospital, Changwon, Korea. FAU - Lee, Won-Young AU - Lee WY AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. LA - eng PT - Journal Article DEP - 20240202 PL - Korea (South) TA - Diabetes Metab J JT - Diabetes & metabolism journal JID - 101556588 SB - IM OTO - NOTNLM OT - Diabetes mellitus, type 2 OT - Insulin resistance OT - Non-alcoholic fatty liver disease OT - Obesity EDAT- 2024/02/05 00:42 MHDA- 2024/02/05 00:42 CRDT- 2024/02/04 18:46 PHST- 2023/10/04 00:00 [received] PHST- 2024/12/26 00:00 [accepted] PHST- 2024/02/05 00:42 [medline] PHST- 2024/02/05 00:42 [pubmed] PHST- 2024/02/04 18:46 [entrez] AID - dmj.2023.0350 [pii] AID - 10.4093/dmj.2023.0350 [doi] PST - aheadofprint SO - Diabetes Metab J. 2024 Feb 2. doi: 10.4093/dmj.2023.0350.